YOUR LENTIVIRUS
SPECIALIZED PARTNER
Lentiviral vector GMP CDMO
DEVELOPMENT AND MANUFACTURING
LENTIVIRAL VECTOR GMP CDMO
Our main aim is to adapt to your own requirements from a technical and timeline perspective
R&D
LENTIVIRAL VECTOR R&D
Our main aim is to implement a technology development strategy focused on providing a response to the main hurdles that currently exist within the gene therapy field
LATEST NEWS
26 February 2021
VIVEbiotech finalist of the National SME 2020 Award
24 February 2021
VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors
21 January 2021
VIVEbiotech and Polyplus-transfection give a webinar on Cell & Gene Therapy Insights
16 December 2020
VIVEbiotech winner of the 2020 Gipuzkoa SME Award
CONTACT OUR EXPERTS FOR FURTHER DISCUSSION
